Sanofi India Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Sanofi India has filed a disclosure with the stock exchange under Regulation 30 of SEBI's Listing Regulations. Regulation 30 requires listed companies to inform the exchange about material events or developments that could affect investors' decisions. The headline alone does not specify what the actual disclosure pertains to — it could relate to board changes, financial results, a business update, an order from a regulator, a new product, or any other material event. Without the attached document or further details, the exact nature of the disclosure cannot be determined from the headline alone. Shareholders should look at the full filing for the actual content of the disclosure.